These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15018019)

  • 21. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
    J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The evaluation of cilazapril efficacy in patients with stable arterial hypertension (a randomized study)].
    Belousov IuB; Akhadov ShV; Leonova MV; Volkov MG
    Ter Arkh; 1995; 67(9):53-6. PubMed ID: 7495044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of cilazapril on left ventricular function and myocardial perfusion in patients with essential hypertension (hypertensive disease) stage II].
    Karpov RS; Pavliukova EN; Kapishchenko TD; Chernov VI
    Ter Arkh; 1995; 67(9):50-3. PubMed ID: 7495043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of cilazapril and prazosin on insulin sensitivity in patients with essential hypertension].
    Cirić J; Zarković M; Trbojević B; Tasić N; Nesović M
    Med Pregl; 1995; 48(9-10):326-8. PubMed ID: 8628189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic effects of chronic treatment by cilazapril in normotensive patients with obliterative arterial diseases of the lower limbs].
    Laurent S; Becquemont L; Laloux B; Asmar R; Hugue C; Vayssairat M; Billaud E; Bauthier P; Cohen N; Houri L
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):987-90. PubMed ID: 7755478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
    Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome after pulmonary endarterectomy.
    Corsico AG; D'Armini AM; Cerveri I; Klersy C; Ansaldo E; Niniano R; Gatto E; Monterosso C; Morsolini M; Nicolardi S; Tramontin C; Pozzi E; Viganò M
    Am J Respir Crit Care Med; 2008 Aug; 178(4):419-24. PubMed ID: 18556630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD; Chatterjee K; De Marco T
    J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of cilazapril on insulin sensitivity in patients with essential arterial hypertension].
    Micic D; Bojovic Lj
    Srp Arh Celok Lek; 2001; 129(5-6):124-8. PubMed ID: 11797459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tadalafil improves oxygenation in a model of newborn pulmonary hypertension.
    Tessler RB; Zadinello M; Fiori H; Colvero M; Belik J; Fiori RM
    Pediatr Crit Care Med; 2008 May; 9(3):330-2. PubMed ID: 18446109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AaDO2 as a predictor of pulmonary hypertension resulting from pulmonary emboli.
    Oswald-Mammosser M; Albert RK; Weitzenblum E; Schrijen F
    Cor Vasa; 1991; 33(3):235-43. PubMed ID: 1914474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.